Suppliers / Apicore Llc (A Wholly Owned Sub Of Rk Pharma

Apicore Llc (A Wholly Owned Sub Of Rk Pharma

United States Updated 9 July 2026

The public registers hold a second record for Apicore Llc (A Wholly Owned Sub Of Rk Pharma. The fuller profile, with 35 active US DMFs and 1 valid CEPs, is at Apicore. Figures on this page cover only this record.

Apicore Llc (A Wholly Owned Sub Of Rk Pharma is an API manufacturer based in United States. It holds 11 active US drug master files across a filed portfolio of 11 molecules.

11
active US DMFs
0
valid CEPs
0
registered plants
0
filings across 0 regulators

What they file, and where

Questions about Apicore Llc (A Wholly Owned Sub Of Rk Pharma

Does Apicore Llc (A Wholly Owned Sub Of Rk Pharma hold a US DMF or a CEP?
Apicore Llc (A Wholly Owned Sub Of Rk Pharma holds 11 active US drug master files. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
What does Apicore Llc (A Wholly Owned Sub Of Rk Pharma make?
11 molecules are on record against Apicore Llc (A Wholly Owned Sub Of Rk Pharma, including Cetrorelix, Degarelix, Indocyanine Green and Maralixibat. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Apicore Llc (A Wholly Owned Sub Of Rk Pharma comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability